ArticleWorld journal of critical care medicine2026
Outcomes of acute kidney injury in critically ill adults with tropical acute febrile illness: Prospective observational study.
Article in World journal of critical care medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTropical acute febrile illness (TAFI) is a major illness with a large number of intensive care unit (ICU) admissions in tropical regions. It is frequently complicated by acute kidney injury (AKI) and associated poor outcomes. The data on the predictors of outcomes, in terms of in-hospital mortality and renal outcomes, amongst critically-ill TAFI patients from our region remain limited.
aimTo evaluate the clinical profile and outcomes of AKI amongst critically-ill TAFI patients and to identify the factors associated with in-hospital mortality.
methodsThis prospective observational cohort study was conducted amongst the patients admitted in ICU at a tertiary care teaching hospital in the state of Rajasthan (India) between June and September 2025. Adult patients (aged ≥ 18 years), with laboratory-confirmed TAFI and AKI diagnosed using AKI network criteria, were included in the study. Demographic, clinical, laboratory, and organ-support variables were recorded. The primary outcome was all-cause in-hospital mortality while the secondary outcomes included renal recovery at the time of discharge and a composite net negative outcome (NNO) (defined as in-hospital mortality or persistent renal dysfunction during discharge). Univariate and exploratory multivariable logistic regression analyses were conducted to identify the predictors of the outcomes.
resultsThe data collected from a total of 68 critically-ill TAFI patients with AKI was analyzed. Their median age was 52 years while 37 (54.4%) were females. Scrub typhus 43 (63.24%) was found to be the most common etiology, followed by dengue 9 (13.24%). AKI stage I was found to be the most frequent (37; 54.4%) at ICU admission, while 19 (27.94%) required renal replacement therapy. Overall, the in-hospital mortality was 8 (11.8%) while NNO was observed in 23 (33.8%) patients. In terms of multivariable analysis, higher APACHE II scores and lower arterial oxygen tension at admission independently predicted the mortality. Dialysis requirement was found to be a strong predictor of NNO (odds ratio 21.95), along with hypoxemia and greater illness severity.
conclusionAKI in critically-ill TAFI patients has the modest mortality yet it results in substantial morbidity and incomplete renal recovery outcomes. Early hypoxemia, illness severity, and the need for dialysis are the key predictors of adverse outcomes. The study findings emphasize the importance of a comprehensive severity assessment beyond the existing creatinine-based AKI staging method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.